| Asal Naderi, MD | |
|
1520 San Pablo St Ste 1000, Los Angeles, CA 90033-5312 | |
| (323) 442-5100 | |
| Not Available |
| Full Name | Asal Naderi |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 14 Years |
| Location | 1520 San Pablo St Ste 1000, Los Angeles, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275859027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A119663 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Keck Hospital Of Usc | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usc Care Medical Group Inc | 0446157747 | 1128 |
News Archive
A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.
IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired the hospitalist practice of Arizona Medical Services, P.C., d.b.a. Old Pueblo Medical Consultants (Old Pueblo) in Tucson, Arizona.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, is adding to its portfolio of drug delivery technologies through the acquisition of a versatile PEG-based technology. The technology covers a series of PEG-grafted cationic polymers that have a wide variety of applications in the pharmaceutical arena.
› Verified 1 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760430847 PECOS PAC ID: 7416869516 Enrollment ID: O20031118000906 |
News Archive
A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.
IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired the hospitalist practice of Arizona Medical Services, P.C., d.b.a. Old Pueblo Medical Consultants (Old Pueblo) in Tucson, Arizona.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, is adding to its portfolio of drug delivery technologies through the acquisition of a versatile PEG-based technology. The technology covers a series of PEG-grafted cationic polymers that have a wide variety of applications in the pharmaceutical arena.
› Verified 1 days ago
| Entity Name | Usc Care Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902846306 PECOS PAC ID: 0446157747 Enrollment ID: O20050512000412 |
News Archive
A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.
IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired the hospitalist practice of Arizona Medical Services, P.C., d.b.a. Old Pueblo Medical Consultants (Old Pueblo) in Tucson, Arizona.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, is adding to its portfolio of drug delivery technologies through the acquisition of a versatile PEG-based technology. The technology covers a series of PEG-grafted cationic polymers that have a wide variety of applications in the pharmaceutical arena.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Asal Naderi, MD Po Box 31309, Los Angeles, CA 90031-0309 Ph: (323) 442-5100 | Asal Naderi, MD 1520 San Pablo St Ste 1000, Los Angeles, CA 90033-5312 Ph: (323) 442-5100 |
News Archive
A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.
IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired the hospitalist practice of Arizona Medical Services, P.C., d.b.a. Old Pueblo Medical Consultants (Old Pueblo) in Tucson, Arizona.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, is adding to its portfolio of drug delivery technologies through the acquisition of a versatile PEG-based technology. The technology covers a series of PEG-grafted cationic polymers that have a wide variety of applications in the pharmaceutical arena.
› Verified 1 days ago
Dr. Robert W Eitches, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8631 W 3rd St, 925e, Los Angeles, CA 90048 Phone: 310-657-4600 Fax: 310-657-6020 | |
Renata G. Lubens, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Dr. Barry Allen Kohn, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 7095 Hollywood Blvd, #635, Los Angeles, CA 90028 Phone: 323-436-0516 Fax: 323-436-0517 | |
Dr. Jean Marie Hanley, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1801 E. Marengo St., L-902, Los Angeles County Usc Division Of Allergy, Los Angeles, CA 90033 Phone: 323-226-3823 Fax: 323-226-3732 | |
Richard M Harris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1125 S Beverly Dr, Suite 740, Los Angeles, CA 90035 Phone: 310-275-0380 Fax: 310-275-1210 | |
Christina Hong Lee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11301 Wilshire Blvd, Bldg 500, 111r, Los Angeles, CA 90073 Phone: 310-478-3711 | |
Emily Hao-yun Liang, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4733 W Sunset Blvd, 3rd Floor, Los Angeles, CA 90027 Phone: 323-783-4516 |